Drug Profile

Oxymetholone

Alternative Names: Anadrol-50; CI 406

Latest Information Update: 27 Feb 2008

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Unimed Pharmaceuticals
Class Androstanols; Antianaemics; Small molecules
Mechanism of Action Protein synthesis stimulants; Stem cell stimulants; Testosterone congener stimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Anaemia
Discontinued Cachexia

Most Recent Events

23 Feb 2001 A study has been added to the Metabolic Disorders therapeutic trials section
14 Jul 1998 Investigation in Cachexia in USA (PO)
14 Jul 1998 Launched for Anaemia in USA (PO)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com